Announcement on the Subsidiary Becoming the Marketing Authorization Holder of Amisulpride Orally Disintegrating Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment